Cautious Optimism: What to Expect as Markets Open on August 10
- Aug 10
- 6 min read
Based on market data as of 07:04 IST on 10 August 2026.
At a glance
GIFT Nifty signals a positive open, backed by FPI (Foreign Portfolio Investor) inflows of ₹12,921 crore in the first week of August and record forex reserves of $692.87 billion.
Q1 FY27 earnings are broadly strong — SBI profit up 10%, Lupin PAT (Profit After Tax) up 16%, Premier Energies up 53% — with 2,045 companies still to report this week.
Brent crude above $84 per barrel and a US Senate bill threatening 100% tariffs on Indian petroleum imports are the two biggest clouds over an otherwise constructive morning.
The setup
Monday morning brings a cautiously constructive mood to Dalal Street. Overnight, Asian stocks edged higher on Gulf peace-talk optimism, Europe's STOXX 600 closed at an all-time high, and US Treasury yields fell after soft July jobs data reduced the probability of a Federal Reserve rate hike. GIFT Nifty — the offshore futures contract that traders use to gauge where the Nifty 50 will open — is pointing to a firm start. The prior session saw the Sensex fall 456 points and the Nifty drop 65 points, so today's positive cues offer some relief. The key question heading into the session: can strong domestic earnings and steady foreign inflows outweigh the drag from elevated crude and geopolitical noise?
Top 5 sentiment drivers
FII/DII flow sentiment. FPIs (Foreign Portfolio Investors, also called FIIs — Foreign Institutional Investors) poured ₹12,921 crore (approximately ₹129.21 billion) into Indian equities in the first week of August alone, and for the first time in 2026, they turned net buyers in IT stocks, deploying ₹3,358 crore in July. India's forex reserves — the RBI's (Reserve Bank of India's) stockpile of foreign currency — hit a record $692.87 billion, providing a strong buffer for the rupee. This driver is moderately bullish at +0.55.
Earnings momentum and corporate health. The Q1 FY27 (April–June 2027 financial year first quarter) earnings season is delivering broadly positive surprises: SBI (State Bank of India) reported a 10% rise in net profit to ₹21,121 crore, Lupin's PAT rose 16% to ₹1,417 crore, and Premier Energies surged 53% to ₹472 crore. Goldman Sachs has set a Nifty 26,500 target by June 2027. With 2,045 companies — including Tata Motors — still to report this week, the earnings calendar remains a key market mover. This driver is moderately bullish at +0.52.
Key corporate narratives. Beyond the headline numbers, the quality of earnings matters. Lupin's US sales jumped 42% YoY (year-on-year), Apollo Micro Systems grew revenue 88%, and Hitachi Energy doubled its profit to ₹294 crore — all pointing to broad-based corporate health. On the other side, Delhivery's profit fell 65% YoY to ₹32 crore, a reminder that not every sector is firing. The Molbio Diagnostics IPO (Initial Public Offering) of ₹940 crore adds a primary-market angle to watch. This driver is moderately bullish at +0.48.
Pharma and healthcare sentiment. Pharma is one of the clearest bright spots this morning. Lupin's strong US sales, Sun Pharma's growth in India and emerging markets, and Aurobindo Pharma's solid emerging-market performance paint a positive picture for the sector. The one cautionary note is Dr Reddy's, where earnings declined on weaker US sales — a reminder that US market dynamics remain uneven. The Molbio Diagnostics IPO adds fresh primary-market interest to the space. This driver is moderately bullish at +0.50.
US regulatory stance. The US Senate has approved a Russia sanctions bill that could impose 100% tariffs on Indian petroleum imports if India continues buying Russian crude — a significant binary risk for energy costs and the current account. Separately, the US is considering ending a 60-day grace period for foreign workers, which could weigh on Indian IT companies with US operations. The silver lining: soft July US jobs data has pushed Treasury yields lower, which is positive for emerging-market capital flows like India's. This driver is moderately bearish at -0.45.
Sectors in focus
Banking. SBI's Q1 net profit of ₹21,121 crore — up 10% YoY with NII (Net Interest Income, the difference between what a bank earns on loans and pays on deposits) rising 15% — is the anchor positive for the sector this morning. However, RBI draft proposals on NBFC (Non-Banking Financial Company) lending norms and a leverage ratio amendment create a near-term regulatory overhang for financials broadly. Mildly bullish at +0.45.
IT. FPIs turning net buyers in Indian IT for the first time in 2026 is a meaningful sentiment shift. A positive NASDAQ backdrop, Europe's STOXX 600 at all-time highs, and falling US Treasury yields all support the sector's global earnings outlook. The risk is the potential US removal of the 60-day grace period for foreign workers, which could raise operational costs for IT firms. Mildly bullish at +0.42.
Auto and manufacturing. This sector faces the most mixed picture today. Ola Electric's Q1 loss narrowed to ₹336 crore with revenue rebounding 72% quarter-on-quarter, but JK Tyre's profit collapsed 73% due to soaring raw material costs linked to West Asia tensions. Crude above $84 per barrel directly pressures input costs across auto and manufacturing. Tata Motors' Q1 results, due this week, will be a key data point. Mildly bullish at +0.22, but with elevated uncertainty.
Pharma. Pharma is the standout sector heading into today's session. Lupin, Sun Pharma, and Aurobindo are all benefiting from strong India and emerging-market demand that is offsetting a softer US environment. The Molbio Diagnostics IPO keeps primary-market interest alive in the healthcare space. Dr Reddy's US weakness is a stock-specific caution rather than a sector-wide concern. Moderately bullish at +0.50.
Global and macro backdrop
Asian markets are opening on a positive note this morning, supported by Gulf peace-talk optimism and the overnight tailwind from Europe. The STOXX 600 hit an all-time high on Friday, driven by strong corporate earnings and soft macro data. In the US, the July jobs report came in below expectations, which has reduced the probability of a Fed (US Federal Reserve) rate hike — a clear positive for emerging markets like India, as lower US rates make Indian assets relatively more attractive.
The key macro negative is Brent crude, which is trading above $84 per barrel — elevated by West Asia geopolitical tensions and shipping-lane concerns in the Gulf. For India, which imports roughly 85% of its crude oil needs, every dollar rise in oil prices widens the trade deficit and adds to inflation pressure. India's forex reserves at a record $692.87 billion — up $10.5 billion in the week to July 31 — provide a meaningful buffer for the rupee and give the RBI room to manage currency volatility. The government is also engaging PSU (Public Sector Undertaking) banks to attract foreign capital and stabilise the rupee. The RBI is conducting a ₹2,00,000 crore (₹2 trillion) VRRR (Variable Rate Reverse Repo, a tool the RBI uses to absorb excess liquidity from the banking system) auction today, signalling active liquidity management.
Risks to watch
US Russia sanctions bill: If enacted, 100% tariffs on Indian petroleum imports would significantly raise India's energy import costs and disrupt the discounted Russian crude supply that has benefited Indian refiners.
Brent crude above $84: Sustained elevated crude prices pressure the current account deficit, inflation, and input costs across auto, chemicals, and manufacturing.
RBI regulatory pipeline: Multiple draft proposals — on NBFC lending norms, the CVA (Credit Valuation Adjustment) framework, and leverage ratio amendments — create uncertainty for banking and financial stocks in the near term.
Earnings season volatility: With 2,045 companies reporting Q1 results this week, individual stock moves could be sharp in both directions, adding intraday noise to index-level moves.
What this means for today's session
Today's session is likely to open on a positive note, with GIFT Nifty and overnight global cues providing the initial lift. Strong earnings from SBI, Lupin, and Premier Energies give the market a domestic anchor. However, the rally's ceiling is capped by crude above $84 and the binary risk of the US sanctions bill — two factors that could quickly shift sentiment if fresh headlines emerge. Expect the market to be data-sensitive and stock-specific, with pharma and banking likely to attract the most attention in early trade.
How to read this
What this sentiment is measuring. We score 16 distinct dimensions of market sentiment, covering broad market direction, key sectors (banking, IT, auto and manufacturing, pharma), global cues, FII / DII flows, currency and commodities, regulatory stance across India and major foreign jurisdictions, and risk indicators. Each dimension is given a score from −1 (strongly bearish) to +1 (strongly bullish), paired with a 0 to 1 confidence weight that reflects how much supporting evidence the model found. The overall score shown in the dial is a confidence-weighted blend of all dimensions on the same −1 to +1 scale.
What data is used. The analysis draws on Indian and global financial news, regulatory and policy feeds from India as well as major foreign jurisdictions, and market news from global exchanges. News items are filtered for freshness and relevance before being scored, so the picture reflects what the market is reading and reacting to right now.
Limitations. This article is not investment advice and not a recommendation to buy, sell, or hold any security. The output is best treated as a structured attribute set — useful as one input among many when building your own prediction models or sense-checking your own view, not as a forecast on its own.
Comments